{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,30]],"date-time":"2025-12-30T22:48:57Z","timestamp":1767134937816,"version":"build-2238731810"},"update-to":[{"DOI":"10.1002\/14651858.cd007783.pub2","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2020,7,1]],"date-time":"2020-07-01T00:00:00Z","timestamp":1593561600000}}],"reference-count":43,"publisher":"Wiley","issue":"7","content-domain":{"domain":["wiley.com","cochranelibrary.com"],"crossmark-restriction":true},"short-container-title":[],"DOI":"10.1002\/14651858.cd007783.pub3","type":"journal-article","created":{"date-parts":[[2020,7,1]],"date-time":"2020-07-01T09:12:35Z","timestamp":1593594755000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Lamotrigine add-on therapy for drug-resistant generalised tonic-clonic seizures"],"prefix":"10.1002","volume":"2020","author":[{"given":"Rebecca","family":"Bresnahan","sequence":"additional","affiliation":[{"name":"Department of Molecular and Clinical Pharmacology; Institute of Translational Medicine, University of Liverpool; Liverpool UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mariangela","family":"Panebianco","sequence":"additional","affiliation":[{"name":"Department of Molecular and Clinical Pharmacology; Institute of Translational Medicine, University of Liverpool; Liverpool UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anthony G","family":"Marson","sequence":"additional","affiliation":[{"name":"Department of Molecular and Clinical Pharmacology; Institute of Translational Medicine, University of Liverpool; Liverpool UK"},{"name":"The Walton Centre NHS Foundation Trust; Liverpool UK"},{"name":"Liverpool Health Partners; Liverpool UK"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2020,7,1]]},"reference":[{"issue":"12","key":"10.1002\/14651858.CD007783.pub3-BIB0001|cit1","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1111\/j.1528-1157.1998.tb01332.x","article-title":"Double-blind placebo-controlled, crossover study of lamotrigine in treatment-resistant generalised epilepsy","volume":"39","author":"Beran","year":"1998","journal-title":"Epilepsia"},{"key":"10.1002\/14651858.CD007783.pub3-BIB0002|cit2","doi-asserted-by":"crossref","first-page":"1737","DOI":"10.1212\/01.wnl.0000187118.19221.e4","article-title":"Double-blind, placebo-controlled study of lamotrigine in primary generalized tonic-clonic seizures","volume":"65","author":"Biton","year":"2005","journal-title":"Neurology"},{"key":"10.1002\/14651858.CD007783.pub3-BIB0003|cit3","unstructured":"A Multi-Center, Double-Blind, Randomized, Placebo-Controlled, Parallel-Group Evaluation of Lamotrigine Adjunctive Therapy in Subjects With Primary Generalized Tonic-Clonic Seizures (Study GI267119) www.gsk-studyregister.com\/study?uniqueStudyId=LAM40097"},{"key":"10.1002\/14651858.CD007783.pub3-BIB0004|cit4","unstructured":"Treatment of primary generalized tonic-clonic seizures with an investigational new drug https:\/\/clinicaltrials.gov\/ct2\/show\/NCT00043901"},{"issue":"S4","key":"10.1002\/14651858.CD007783.pub3-BIB0005|cit5","first-page":"47","article-title":"Evaluation of lamotrigine adjunctive therapy for primary generalized tonic-clonic seizures in patients with a history of absence epilepsy","volume":"47","author":"Tabbaa","year":"2006","journal-title":"Epilepsia"},{"issue":"2","key":"10.1002\/14651858.CD007783.pub3-BIB0006|cit6","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1542\/peds.2006-0148","article-title":"Lamotrigine adjunctive therapy among children and adolescents with primary generalized tonic-clonic seizures","volume":"118","author":"Trevathan","year":"2006","journal-title":"Paediatrics"},{"issue":"3","key":"10.1002\/14651858.CD007783.pub3-BIB0007|cit7","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1016\/j.yebeh.2010.07.022","article-title":"Adjunctive lamotrigine XR for primary generalized tonic-clonic seizures in a randomized, placebo-controlled study","volume":"19","author":"Biton","year":"2010","journal-title":"Epilepsy & Behavior"},{"key":"10.1002\/14651858.CD007783.pub3-BIB0008|cit8","unstructured":"A multicenter, double-blind, randomized, parallel-group evaluation of LAMICTAL extended-release adjunctive therapy in subjects with primary generalized tonic-clonic seizures www.clinicaltrialsregister.eu\/ctr-search\/search?query=2004-004343-21"},{"key":"10.1002\/14651858.CD007783.pub3-BIB0009|cit9","unstructured":"A multicenter, double-blind, randomized, parallel-group evaluation of LAMICTAL extended-release adjunctive therapy in subjects with primary generalized tonic-clonic seizures www.gsk-studyregister.com\/study?uniqueStudyId=LAM100036"},{"key":"10.1002\/14651858.CD007783.pub3-BIB0010|cit10","unstructured":"A multicenter, double-blind, randomized, parallel-group evaluation of LAMICTAL extended-release adjunctive therapy in patients with primary generalized tonic-clonic seizures clinicaltrials.gov\/ct2\/show\/study\/NCT00104416"},{"issue":"6","key":"10.1002\/14651858.CD007783.pub3-BIB0011|cit11","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1111\/j.1365-2710.2012.01351.x","article-title":"Impact of age, weight and concomitant treatment on lamotrigine pharmacokinetics","volume":"37","author":"Brzakovic","year":"2012","journal-title":"Journal of Clinical Pharmacy and Therapeutics"},{"issue":"1","key":"10.1002\/14651858.CD007783.pub3-BIB0012|cit12","doi-asserted-by":"crossref","first-page":"e6","DOI":"10.4081\/ni.2009.e6","article-title":"Cognitive effects of lamotrigine versus topiramate as adjunctive therapy in older adults with epilepsy","volume":"1","author":"Chung","year":"2009","journal-title":"Neurology International"},{"issue":"5","key":"10.1002\/14651858.CD007783.pub3-BIB0013|cit13","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1111\/j.1528-1157.1998.tb01411.x","article-title":"The efficacy of lamotrigine in children and adolescents with refractory generalized epilepsy: a randomized, double-blind, crossover study","volume":"39","author":"Eriksson","year":"1998","journal-title":"Epilepsia"},{"key":"10.1002\/14651858.CD007783.pub3-BIB0014|cit14","doi-asserted-by":"crossref","first-page":"1807","DOI":"10.1056\/NEJM199712183372504","article-title":"Lamotrigine for generalized seizures associated with the Lennox-Gastaut syndrome","volume":"337","author":"Motte","year":"1997","journal-title":"New England Journal of Medicine"},{"key":"10.1002\/14651858.CD007783.pub3-BIB0015|cit15","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/0920-1211(90)90077-9","article-title":"A randomised double-blind placebo-controlled add-on trial of lamotrigine in patients with severe epilepsy","volume":"6","author":"Sander","year":"1990","journal-title":"Epilepsy Research"},{"key":"10.1002\/14651858.CD007783.pub3-BIB0016|cit16","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1111\/j.1528-1157.1989.tb05316.x","article-title":"Proposal for revised clinical and electroencephalographic classification of epileptic seizures","volume":"30","author":"Bancaud","year":"1989","journal-title":"Epilepsia"},{"issue":"2","key":"10.1002\/14651858.CD007783.pub3-BIB0017|cit17","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1111\/j.1528-1157.1998.tb01356.x","article-title":"Carbamazepine toxicity with lamotrigine: pharmacokinetic or pharmacodynamic interaction?","volume":"39","author":"Besag","year":"1998","journal-title":"Epilepsia"},{"issue":"1","key":"10.1002\/14651858.CD007783.pub3-BIB0018|cit18","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1590\/abd1806-4841.20175070","article-title":"Identifying the incidence of rash, Stevens-Johnson syndrome and toxic epidermal necrolysis in patients taking lamotrigine: a systematic review of 122 randomized controlled trials","volume":"92","author":"Bloom","year":"2017","journal-title":"Anais Brasileiros De Dermatologia"},{"issue":"2","key":"10.1002\/14651858.CD007783.pub3-BIB0019|cit19","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD003032.pub4","article-title":"Ethosuximide, sodium valproate or lamotrigine for absence seizures in children and adolescents","author":"Brigo","year":"2019","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"8968","key":"10.1002\/14651858.CD007783.pub3-BIB0020|cit20","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/S0140-6736(95)91208-8","article-title":"Remission of epilepsy: results from the National General Practice Study of Epilepsy","volume":"346","author":"Cockerell","year":"1995","journal-title":"Lancet"},{"issue":"6","key":"10.1002\/14651858.CD007783.pub3-BIB0021|cit21","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1166\/jbn.2013.1599","article-title":"A comparison of extracellular excitatory amino acids release inhibition of acute lamotrigine and topiramate treatment in the hippocampus of PTZ-kindled epileptic rats","volume":"9","author":"Deng","year":"2013","journal-title":"Journal of Biomedical Nanotechnology"},{"issue":"3","key":"10.1002\/14651858.CD007783.pub3-BIB0022|cit22","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1212\/WNL.0000000000003509","article-title":"Prevalence and incidence of epilepsy: a systematic review and meta-analysis of international studies","volume":"88","author":"Fiest","year":"2017","journal-title":"Neurology"},{"key":"10.1002\/14651858.CD007783.pub3-BIB0023|cit23","unstructured":"McMaster University (developed by Evidence Prime) GRADEpro GDT"},{"issue":"4","key":"10.1002\/14651858.CD007783.pub3-BIB0024|cit24","first-page":"289","article-title":"Sample size estimation in epidemiologic studies","volume":"2","author":"Hajian-Tilaki","year":"2011","journal-title":"Caspian Journal of Internal Medicine"},{"issue":"2","key":"10.1002\/14651858.CD007783.pub3-BIB0025|cit25","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD003277.pub3","article-title":"Treatment of Lennox-Gastaut syndrome","author":"Hancock","year":"2013","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"10.1002\/14651858.CD007783.pub3-BIB0026|cit26","unstructured":"Higgins JPT Green S Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011 Available from handbook.cochrane.org"},{"key":"10.1002\/14651858.CD007783.pub3-BIB0027|cit27","unstructured":"Higgins JPT Altman DG Sterne JAC Chapter 8: Assessing risk of bias in included studies. In: Higgins JP, Churchill R, Chandler J, Cumpston MS, editor(s), Cochrane Handbook for Systematic Reviews of Interventions version 5.2.0 (updated June 2017). The Cochrane Collaboration, 2017 Available from www.training.cochrane.org\/handbook"},{"issue":"1","key":"10.1002\/14651858.CD007783.pub3-BIB0028|cit28","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0197-2456(95)00134-4","article-title":"Assessing the quality of reports or randomized clinical trials: is blinding necessary?","volume":"17","author":"Jadad","year":"1996","journal-title":"Controlled Clinical Trials"},{"issue":"5","key":"10.1002\/14651858.CD007783.pub3-BIB0029|cit29","doi-asserted-by":"crossref","first-page":"642","DOI":"10.4088\/JCP.v66n0516","article-title":"Dermatology precautions and slower titration yield low incidence of lamotrigine treatment-emergent rash","volume":"66","author":"Ketter","year":"2005","journal-title":"The Journal of Clinical Psychiatry"},{"issue":"2","key":"10.1002\/14651858.CD007783.pub3-BIB0030|cit30","doi-asserted-by":"crossref","first-page":"117","DOI":"10.4103\/ijd.IJD_583_17","article-title":"Management of Stevens-Johnson syndrome-toxic epidermal necrolysis: looking beyond guidelines!","volume":"63","author":"Kumar","year":"2018","journal-title":"Indian Journal of Dermatology"},{"issue":"6","key":"10.1002\/14651858.CD007783.pub3-BIB0031|cit31","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1111\/j.1528-1167.2009.02397.x","article-title":"Definition of drug resistant epilepsy: consensus proposal by the ad hoc Task Force of the ILAE Commission on Therapeutic Strategies","volume":"51","author":"Kwan","year":"2010","journal-title":"Epilepsia"},{"key":"10.1002\/14651858.CD007783.pub3-BIB0032|cit32","volume-title":"Mechanisms of Action in Antiepileptic Drugs","author":"Leach","year":"1995"},{"key":"10.1002\/14651858.CD007783.pub3-BIB0033|cit33","unstructured":"Lefebvre C Manheimer E Glanville J Chapter 6: Searching for studies. In: Higgins JPT, Green S, editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011 Available from handbook.cochrane.org"},{"issue":"2","key":"10.1002\/14651858.CD007783.pub3-BIB0034|cit34","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1017\/S1461145708009504","article-title":"Lamotrigine-associated rash: to rechallenge or not to rechallenge?","volume":"12","author":"Lorberg","year":"2009","journal-title":"The International Journal of Neuropsychopharmacology"},{"key":"10.1002\/14651858.CD007783.pub3-BIB0035|cit35","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1016\/S0140-6736(07)60461-9","article-title":"The SANAD study of effectiveness of valproate, lamotrigine, or topiramate for generalised and unclassifiable epilepsy: an unblinded randomised controlled trial","volume":"369","author":"Marson","year":"2007","journal-title":"Lancet"},{"issue":"6","key":"10.1002\/14651858.CD007783.pub3-BIB0036|cit36","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD001909.pub2","article-title":"Lamotrigine add-on for drug-resistant partial epilepsy","author":"Ramaratnam","year":"2016","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"10.1002\/14651858.CD007783.pub3-BIB0037|cit37","unstructured":"Nordic Cochrane Centre, The Cochrane Collaboration Review Manager 5 (RevMan 5) 2014"},{"issue":"6","key":"10.1002\/14651858.CD007783.pub3-BIB0038|cit38","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1124\/dmd.106.009340","article-title":"In vitro characterization of lamotrigine N2-glucuronidation and the lamotrigine-valproic acid interaction","volume":"34","author":"Rowland","year":"2006","journal-title":"Drug Metabolism and Disposition"},{"key":"10.1002\/14651858.CD007783.pub3-BIB0039|cit39","unstructured":"Sch\u00fcnemann H Bro\u017cek J Guyatt G Oxman A Handbook for grading the quality of evidence and the strength of recommendations using the GRADE approach (updated October 2013). GRADE Working Group, 2013 Available from gdt.guidelinedevelopment.org\/app\/handbook\/handbook.html"},{"issue":"9","key":"10.1002\/14651858.CD007783.pub3-BIB0040|cit40","doi-asserted-by":"crossref","first-page":"1432","DOI":"10.1001\/archneur.62.9.1432","article-title":"Effect of antiepileptic drug co-medication on lamotrigine clearance","volume":"62","author":"Weintraub","year":"2005","journal-title":"Archives of Neurology"},{"key":"10.1002\/14651858.CD007783.pub3-BIB0041|cit41","unstructured":"World Health Organization (WHO) Epilepsy www.who.int\/news-room\/fact-sheets\/detail\/epilepsy"},{"issue":"2","key":"10.1002\/14651858.CD007783.pub3-BIB0042|cit42","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD007783","article-title":"Lamotrigine add-on for refractory generalized tonic-clonic seizures","author":"Tjia-Leong","year":"2009","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"12","key":"10.1002\/14651858.CD007783.pub3-BIB0043|cit43","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD007783.pub2","article-title":"Lamotrigine adjunctive therapy for refractory generalized tonic-clonic seizures","author":"Tjia-Leong","year":"2010","journal-title":"Cochrane Database of Systematic Reviews"}],"container-title":["Cochrane Database of Systematic Reviews"],"original-title":[],"language":"en","deposited":{"date-parts":[[2024,8,8]],"date-time":"2024-08-08T20:26:21Z","timestamp":1723148781000},"score":1,"resource":{"primary":{"URL":"http:\/\/doi.wiley.com\/10.1002\/14651858.CD007783.pub3"}},"subtitle":[],"editor":[{"name":"Cochrane Epilepsy Group","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2020,7,1]]},"references-count":43,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2020,7]]}},"URL":"https:\/\/doi.org\/10.1002\/14651858.cd007783.pub3","relation":{},"ISSN":["1465-1858"],"issn-type":[{"value":"1465-1858","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,7,1]]}}}